BioXcel Therapeutics, Inc.BTAI
BTAI on Nasdaq: pharmaceutical preparations.
Listed on Nasdaq, BioXcel Therapeutics, Inc. (BTAI) sits within the healthcare sector operating in pharmaceutical preparations.
Detailed business segments for BioXcel Therapeutics, Inc. aren't currently in our reference dataset.
What the trading floor has done with BTAI.
Below is the outcome history for BTAI from Sensei's alert feed. Entry, target, and stop levels — plus the chart-level reasoning — are members-only.
- BUYMar 5, 2026Hit+4.78%
- BUYAug 6, 2025Hit+18.02%
- BUYAug 5, 2025Hit+43.80%
- BUYAug 4, 2025Hit+51.10%
- BUYAug 1, 2025Hit+20.69%
- BUYMar 5, 2025Hit+5.83%
- BUYOct 25, 2023Hit+8.48%
- BUYOct 25, 2023Hit+11.88%
- BUYOct 25, 2023Hit+23.45%
- BUYJul 6, 2023Hit+8.24%
Full details unlock inside the app
Common questions about this stock.
What is BTAI?
BTAI is the trading symbol for BioXcel Therapeutics, Inc., listed on Nasdaq in the healthcare sector.
What sector is BTAI in?
BioXcel Therapeutics, Inc. (BTAI) is classified in the healthcare sector — specifically pharmaceutical preparations, based on its SEC SIC classification.
Has Sensei traded BTAI?
Yes — BTAI has appeared in the Sensei alert feed 10 times, including 10 calls that hit target. The "Sensei's calls on BTAI" section above lists the recent history; entry, target, and stop levels are members-only.
Where does BTAI trade?
BTAI trades on Nasdaq.
Is BTAI a stock or an ETF?
BTAI is a publicly-traded common stock, not an ETF.
Trade BTAI alongside Sensei.
Live alerts, a focused community, and the full course library. $60/month. Cancel anytime.